EverSource Wealth Advisors »

Aeglea Biotherapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 65 16.74
2025-06-30 $972 65 14.96
2025-03-31 $387 24 16.13
2024-12-31 $186 8 23.25

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics